TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
DrugtestScandinavia AB
Closing information (x1000 NOK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
2,838
|
2,208
|
1,696 |
Financial expenses |
0
|
26
|
0 |
Earnings before taxes |
-316
|
-22
|
144 |
EBITDA |
-325
|
4
|
131 |
Total assets |
1,353
|
1,813
|
1,664 |
Current assets |
1,353
|
1,567
|
1,612 |
Current liabilities |
1,247
|
767
|
525 |
Equity capital |
106
|
1,046
|
1,102 |
- share capital |
101
|
95
|
98 |
Employees (average) |
2
![]() |
2
![]() |
2 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
7.8%
|
57.7%
|
66.2% |
Turnover per employee |
1,419
|
1,104
|
848 |
Profit as a percentage of turnover |
-11.1%
|
-1.0%
|
8.5% |
Return on assets (ROA) |
-23.4%
|
0.2%
|
8.7% |
Current ratio |
108.5%
|
204.3%
|
307.0% |
Return on equity (ROE) |
-298.1%
|
-2.1%
|
13.1% |
Change turnover |
473
|
563
|
-39 |
Change turnover % |
20%
|
34%
|
-2% |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
0%
![]() |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.